According to Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the company, has completed the public offering of the second 2026 corporate bonds in China. The second 2026 corporate bond with a principal amount of RMB 900 million has been issued, with a term of three years and an annual coupon interest rate of 1.48%.

Zhitongcaijing · 2d ago
According to Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the company, has completed the public offering of the second 2026 corporate bonds in China. The second 2026 corporate bond with a principal amount of RMB 900 million has been issued, with a term of three years and an annual coupon interest rate of 1.48%.